Literature DB >> 12110532

Regulation of endogenous glucose production after a mixed meal in type 2 diabetes.

Parag Singhal1, Andrea Caumo, Peter E Carey, Claudio Cobelli, Roy Taylor.   

Abstract

The extent and time course of suppression of endogenous glucose production (EGP) in type 2 diabetes after a mixed meal have been determined using a new tracer methodology. Groups of age-, sex-, and weight-matched normal controls (n = 8) and diet-controlled type 2 diabetic subjects (n = 8) were studied after ingesting a standard mixed meal (550 kcal; 67% carbohydrate, 19% fat, 14% protein). There was an early insulin increment in both groups such that, by 20 min, plasma insulin levels were 266 +/- 54 and 190 +/- 53 pmol/l, respectively. EGP was similar basally [2.55 +/- 0.12 mg x kg(-1) x min(-1) in control subjects vs. 2.92 +/- 0.16 mg x kg(-1) x min(-1) in the patients (P = 0.09)]. After glucose ingestion, EGP declined rapidly in both groups to approximately 50% of basal within 30 min of the meal. Despite the initial rapid decrease, the EGP was significantly greater in the diabetic group at 60 min (1.75 +/- 0.12 vs. 1.05 +/- 0.14 mg x kg(-1) x min(-1); P < 0.01) and did not reach nadir until 210 min (0.96 +/- 0.17 mg x kg(-1) x min(-1)). Between 60 and 240 min, EGP was 47% higher in the diabetic group (0.89 +/- 0.09 vs. 1.31 +/- 0.13 mg x kg(-1) x min(-1), P < 0.02). These data quantitate the initial rapid suppression of EGP after a mixed meal in type 2 diabetes and the contribution of continuing excess glucose production to subsequent hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110532     DOI: 10.1152/ajpendo.00424.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  17 in total

Review 1.  The role of the liver in type 2 diabetes.

Authors:  Peter Staehr; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?

Authors:  Gaurav Chikara; Pramod Kumar Sharma; Pradeep Dwivedi; Jaykaran Charan; Sneha Ambwani; Surjit Singh
Journal:  Indian J Clin Biochem       Date:  2017-06-08

3.  Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.

Authors:  D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; L Leelarathna; C L Acerini; A Haidar; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

4.  Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.

Authors:  Eric D Labonté; R Jason Kirby; Nicholas M Schildmeyer; April M Cannon; Kevin W Huggins; David Y Hui
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 5.  Complex physiology and clinical implications of time-restricted eating.

Authors:  Max C Petersen; Molly R Gallop; Stephany Flores Ramos; Amir Zarrinpar; Josiane L Broussard; Maria Chondronikola; Amandine Chaix; Samuel Klein
Journal:  Physiol Rev       Date:  2022-07-14       Impact factor: 46.500

Review 6.  Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause.

Authors:  R Taylor
Journal:  Diabetologia       Date:  2008-08-26       Impact factor: 10.122

7.  Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Authors:  Ananda Basu; Chiara Dalla Man; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

8.  Banting Memorial lecture 2012: reversing the twin cycles of type 2 diabetes.

Authors:  R Taylor
Journal:  Diabet Med       Date:  2013-03       Impact factor: 4.359

9.  Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study.

Authors:  Roy Eldor; Ehud Arbit; Asher Corcos; Miriam Kidron
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.

Authors:  Balasubramanian Ravikumar; Jean Gerrard; Chiara Dalla Man; Michael J Firbank; Annette Lane; Philip T English; Claudio Cobelli; Roy Taylor
Journal:  Diabetes       Date:  2008-06-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.